WTF is with Nikhil Kamath cover image

Ep #7 | Who is Kiran Mazumdar Shaw Really? And WTF is Biotech?

WTF is with Nikhil Kamath

00:00

Biopharmaceuticals: The Future of Enzymes

Biocon went public in 2000 after pivoting from enzymes to biopharmaceuticals. The company now makes statins using fungal fermentation technologies. AIG calls Biocon's IPO "the best investment they've ever made to date"

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app